Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PX 12

Drug Profile

PX 12

Alternative Names: IV 2 compound; IV-2; PX-12; thioredoxin inhibitor PX-12; thioredoxin-1 inhibitor PX-12

Latest Information Update: 30 Dec 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Arizona
  • Developer National Cancer Institute (USA); Oncothyreon; ProlX Pharmaceuticals; Translational Genomics Research Institute
  • Class Antineoplastics; Disulfides; Imidazoles; Small molecules
  • Mechanism of Action Thioredoxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes - Cancer

Highest Development Phases

  • No development reported Cancer; Gastrointestinal cancer; Pancreatic cancer

Most Recent Events

  • 11 Jun 2008 Phase-Ib clinical trials in advanced or metastatic Cancer in USA (IV)
  • 16 Apr 2008 Pharmacodynamics data from phase I trials in Cancer presented at the 99th Annual Meeting of the American Association for Cancer Research (AACR-2008)
  • 30 Jan 2008 PX 12 is still in phase II trials for advanced Pancreatic cancer in the USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top